DE122009000037I2 - Ein an vero-zellen angepasstes abgeschwächtes japanisches enzephalitis virus und ein impfstoff gegen japanische enzephalitis - Google Patents
Ein an vero-zellen angepasstes abgeschwächtes japanisches enzephalitis virus und ein impfstoff gegen japanische enzephalitisInfo
- Publication number
- DE122009000037I2 DE122009000037I2 DE122009000037C DE122009000037C DE122009000037I2 DE 122009000037 I2 DE122009000037 I2 DE 122009000037I2 DE 122009000037 C DE122009000037 C DE 122009000037C DE 122009000037 C DE122009000037 C DE 122009000037C DE 122009000037 I2 DE122009000037 I2 DE 122009000037I2
- Authority
- DE
- Germany
- Prior art keywords
- enzephalitis
- japanese
- analyzed
- virus
- vero cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010014599 encephalitis Diseases 0.000 title 2
- 241000700605 Viruses Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19970042001 | 1997-08-28 | ||
KR19970042002 | 1997-08-28 | ||
PCT/KR1998/000259 WO1999011762A1 (en) | 1997-08-28 | 1998-08-25 | An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
DE69837211T DE69837211T2 (de) | 1997-08-28 | 1998-08-25 | Ein an vero-zellen angepasstes abgeschwächtes japanische enzephalitis virus und ein impfstoff gegen japanische enzephalitis |
Publications (2)
Publication Number | Publication Date |
---|---|
DE122009000037I1 DE122009000037I1 (de) | 2009-11-05 |
DE122009000037I2 true DE122009000037I2 (de) | 2011-06-16 |
Family
ID=26633032
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE122009000037C Active DE122009000037I2 (de) | 1997-08-28 | 1998-08-25 | Ein an vero-zellen angepasstes abgeschwächtes japanisches enzephalitis virus und ein impfstoff gegen japanische enzephalitis |
DE69837211T Expired - Lifetime DE69837211T2 (de) | 1997-08-28 | 1998-08-25 | Ein an vero-zellen angepasstes abgeschwächtes japanische enzephalitis virus und ein impfstoff gegen japanische enzephalitis |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69837211T Expired - Lifetime DE69837211T2 (de) | 1997-08-28 | 1998-08-25 | Ein an vero-zellen angepasstes abgeschwächtes japanische enzephalitis virus und ein impfstoff gegen japanische enzephalitis |
Country Status (15)
Country | Link |
---|---|
US (1) | US6309650B1 (de) |
EP (2) | EP1604685B1 (de) |
JP (1) | JP4161017B2 (de) |
KR (1) | KR100314404B1 (de) |
CN (1) | CN1142271C (de) |
AU (1) | AU748730B2 (de) |
CA (1) | CA2301000C (de) |
DE (2) | DE122009000037I2 (de) |
DK (2) | DK1604685T3 (de) |
ES (2) | ES2382946T3 (de) |
FR (1) | FR09C0037I2 (de) |
MY (1) | MY129773A (de) |
NL (1) | NL300391I2 (de) |
NZ (1) | NZ503522A (de) |
WO (1) | WO1999011762A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000083657A (ja) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスワクチン |
WO2000020565A1 (fr) | 1998-10-05 | 2000-04-13 | The Research Foundation For Microbial Diseases Of Osaka University | Immunogene ameliore pour un vaccin inactive contre une infection a virus de l'encephalite japonaise et procede de production associe |
DK2251419T3 (da) * | 1999-04-22 | 2012-07-02 | Us Agriculture | Porcint reproduktions- og respirations-syndrom-vaccine baseret på isolat JA-142 |
WO2001076624A1 (fr) * | 2000-04-07 | 2001-10-18 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Vaccin inactive contre l'encephalite japonaise b et procede d'elaboration associe |
CA2451816A1 (en) * | 2001-06-29 | 2003-01-09 | Becton, Dickinson And Company | Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
JP2007068401A (ja) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | 西ナイルウイルスワクチン |
CA2555412C (en) * | 2004-02-23 | 2013-06-25 | Crucell Holland B.V. | Virus purification methods |
CN100340596C (zh) * | 2004-05-20 | 2007-10-03 | 佛山市顺德区汉达精密电子科技有限公司 | 回收聚碳酸酯/丙烯腈-丁二烯-苯乙烯共聚物及其回收方法 |
CA2602944C (en) * | 2005-04-11 | 2015-08-11 | Crucell Holland B.V. | Virus purification using ultrafiltration |
WO2008115314A2 (en) * | 2007-01-31 | 2008-09-25 | Sanofi Pasteur Biologics Co. | Flavivirus vaccine vector against influenza virus |
CN101969994B (zh) * | 2007-12-26 | 2016-08-31 | 北里第一三共疫苗股份有限公司 | 能够稳定地长期保存的日本脑炎疫苗的制造方法及该疫苗的用途 |
US9114098B2 (en) | 2008-06-04 | 2015-08-25 | The Chemo-Sero-Therapeutic Research Institute | Method for using inactivated Japanese encephalitis virus particles as adjuvant |
WO2010013601A1 (ja) * | 2008-07-30 | 2010-02-04 | 久光製薬株式会社 | マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法 |
KR20120027381A (ko) * | 2009-05-25 | 2012-03-21 | 파나세아 바이오테크 리미티드 | 일본뇌염 백신 및 그것의 제조 방법 |
KR101144993B1 (ko) * | 2009-06-18 | 2012-06-27 | 대한민국 | 돼지 일본뇌염 바이러스의 고농축 혈구응집용 항원 |
PT3269386T (pt) | 2011-12-06 | 2022-12-05 | Valneva Austria Gmbh | Compostos de alumínio para utilização em terapêuticas e vacinas |
IN2013CH04135A (de) * | 2013-09-14 | 2015-08-14 | Bharat Biotech Int Ltd | |
CN105695424B (zh) * | 2015-04-01 | 2019-06-14 | 中国食品药品检定研究院 | 乙型脑炎减毒活疫苗株sa14-14-2在人二倍体细胞2bs上的适应株及其疫苗 |
US10660950B2 (en) | 2015-12-23 | 2020-05-26 | Valneva Se | Virus purification |
CA3010049C (en) * | 2016-01-15 | 2021-10-12 | The Chemo-Sero-Therapeutic Research Institute | Vaccine containing immobilized virus particles |
US11033615B2 (en) | 2016-05-31 | 2021-06-15 | The Government of the United States, As Represented by the Secretary of the Army Fort Detrick, Maryland | Zika virus vaccine and methods of production |
BR112020003470B1 (pt) | 2017-09-21 | 2023-09-26 | Valneva Se | Composições farmacêuticas compreendendo o vírus imunogênico de chikungunya chikv-delta5nsp3, processo e uso das mesmas |
BR112020008665A2 (pt) | 2017-11-03 | 2020-11-10 | Takeda Vaccines, Inc. | método para inativar vírus da zika e para determinar a integridade de inativação |
CN116983398A (zh) | 2017-11-30 | 2023-11-03 | 武田疫苗股份有限公司 | 寨卡疫苗和免疫原性组合物以及其使用方法 |
CN110684747B (zh) * | 2018-07-06 | 2024-05-24 | 厦门大学 | 灭活及保存呼吸道合胞病毒的方法 |
JP7376013B2 (ja) * | 2018-08-27 | 2023-11-08 | マイキャン・テクノロジーズ株式会社 | 不死化単球細胞および誘導細胞を用いた抗感染症薬,ワクチンなどの評価方法 |
IL296071A (en) | 2020-03-01 | 2022-11-01 | Valneva Austria Gmbh | Sars-cov-2 virus vaccine with adjuvant cytidine-phosphoguanosine |
EP3895729A1 (de) | 2020-03-01 | 2021-10-20 | Valneva Austria GmbH | Cpg-adjuvanter sars-cov-2-virus-impfstoff |
WO2021204825A2 (en) | 2020-04-06 | 2021-10-14 | Valneva Austria Gmbh | INACTIVATED SARS-CoV-2 VIRUS VACCINE |
WO2023148256A1 (en) | 2022-02-02 | 2023-08-10 | Valneva Austria Gmbh | Inactivated sars-cov-2 virus vaccine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2704258B2 (ja) * | 1987-10-31 | 1998-01-26 | 日本臓器製薬株式会社 | 組み換えワクチニアウイルス |
GB8821656D0 (en) * | 1988-09-15 | 1988-10-12 | Health Lab Service Board | Pharmaceutical compositions for eliciting immunostimulant effect |
JPH085803B2 (ja) * | 1988-11-10 | 1996-01-24 | 武田薬品工業株式会社 | 日本脳炎ワクチンの製造法 |
EP0562136A1 (de) | 1992-03-24 | 1993-09-29 | Division Of Microbiology, Kyoto Biken Laboratories, Inc. | Lebender Impfstoff gegen Getah Virus infektiöse Krankheiten, und dreiwertiger lebender Impfstoff gegen japanische Enkephalitis Virus, Schweinparvovirus und Getah Virus |
US6010894A (en) * | 1997-06-13 | 2000-01-04 | Research Development Foundation | Method of screening for attenuating viruses |
-
1998
- 1998-08-25 DK DK05014317.1T patent/DK1604685T3/da active
- 1998-08-25 DE DE122009000037C patent/DE122009000037I2/de active Active
- 1998-08-25 US US09/486,392 patent/US6309650B1/en not_active Expired - Lifetime
- 1998-08-25 EP EP05014317A patent/EP1604685B1/de not_active Expired - Lifetime
- 1998-08-25 DE DE69837211T patent/DE69837211T2/de not_active Expired - Lifetime
- 1998-08-25 WO PCT/KR1998/000259 patent/WO1999011762A1/en active IP Right Grant
- 1998-08-25 EP EP98941885A patent/EP1025209B1/de not_active Expired - Lifetime
- 1998-08-25 NZ NZ503522A patent/NZ503522A/en not_active IP Right Cessation
- 1998-08-25 ES ES05014317T patent/ES2382946T3/es not_active Expired - Lifetime
- 1998-08-25 ES ES98941885T patent/ES2281929T3/es not_active Expired - Lifetime
- 1998-08-25 CN CNB988097974A patent/CN1142271C/zh not_active Expired - Lifetime
- 1998-08-25 CA CA002301000A patent/CA2301000C/en not_active Expired - Lifetime
- 1998-08-25 DK DK98941885T patent/DK1025209T3/da active
- 1998-08-25 AU AU90047/98A patent/AU748730B2/en not_active Expired
- 1998-08-25 JP JP2000508774A patent/JP4161017B2/ja not_active Expired - Lifetime
- 1998-08-26 MY MYPI98003899A patent/MY129773A/en unknown
- 1998-08-27 KR KR1019980035007A patent/KR100314404B1/ko not_active IP Right Cessation
-
2009
- 2009-06-10 NL NL300391C patent/NL300391I2/nl unknown
- 2009-08-14 FR FR09C0037C patent/FR09C0037I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
WO1999011762A1 (en) | 1999-03-11 |
NL300391I2 (nl) | 2009-11-02 |
ES2382946T3 (es) | 2012-06-14 |
EP1025209B1 (de) | 2007-02-28 |
CN1142271C (zh) | 2004-03-17 |
JP2001514844A (ja) | 2001-09-18 |
NZ503522A (en) | 2001-06-29 |
CA2301000C (en) | 2003-07-08 |
AU748730B2 (en) | 2002-06-13 |
DK1025209T3 (da) | 2007-06-25 |
JP4161017B2 (ja) | 2008-10-08 |
MY129773A (en) | 2007-04-30 |
CN1272879A (zh) | 2000-11-08 |
FR09C0037I1 (de) | 2009-09-25 |
EP1604685A2 (de) | 2005-12-14 |
DE122009000037I1 (de) | 2009-11-05 |
US6309650B1 (en) | 2001-10-30 |
FR09C0037I2 (fr) | 2021-11-05 |
DK1604685T3 (da) | 2012-06-18 |
AU9004798A (en) | 1999-03-22 |
DE69837211D1 (de) | 2007-04-12 |
ES2281929T3 (es) | 2007-10-01 |
DE69837211T2 (de) | 2007-12-06 |
NL300391I1 (nl) | 2009-08-03 |
KR100314404B1 (ko) | 2002-10-12 |
EP1604685A3 (de) | 2006-07-05 |
CA2301000A1 (en) | 1999-03-11 |
EP1025209A1 (de) | 2000-08-09 |
KR19990023955A (ko) | 1999-03-25 |
EP1604685B1 (de) | 2012-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE122009000037I2 (de) | Ein an vero-zellen angepasstes abgeschwächtes japanisches enzephalitis virus und ein impfstoff gegen japanische enzephalitis | |
DE69806477D1 (de) | Mikrotechnologischer strömungs-optischer gassensor | |
ATE272640T1 (de) | Cyclische sulfonderivate | |
DE69803199D1 (de) | Erkennung und entfernung von makroviren | |
DE69922857D1 (de) | Rechnersicherheit durch Virusuntersuchung | |
DE69827307D1 (de) | Turbolader | |
DE69809393D1 (de) | Gasabsorption | |
DE69822808D1 (de) | Strömungsmaschine | |
TR199802625A2 (xx) | Yeni farmas�tikler | |
DE69841009D1 (de) | Gassensor | |
ATE277631T1 (de) | Neospora impstoff | |
IS5277A (is) | théttilok fyrir gashylki | |
NO20011843L (no) | Selektivt replikerende virusvektorer | |
IS5777A (is) | Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess | |
DE69801856D1 (de) | Befestigungselement | |
DE19881472D2 (de) | Gassack | |
DE59801415D1 (de) | Gassack | |
DE69934108D1 (de) | Kombinierte Impfstoffe gegen Hepatitis A und Hepatitis B | |
DE19880533T1 (de) | Spektralanalyse | |
DE69817816D1 (de) | Eine lufttrockneranordnung | |
DK0891803T3 (da) | Gastørreanordning | |
DE59810338D1 (de) | Gassack | |
FR2769951B1 (fr) | Turbocompresseur | |
PT841943E (pt) | Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas | |
NO303697B1 (no) | Innluftstenger |